Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05786456 · ClinicalTrials.gov registry record · NA

e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study

A NA study of Malignant Female Reproductive System Neoplasm and Stage III Ovarian Cancer AJCC v8, sponsored by City of Hope Medical Center.

Active
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT05786456 is a NA study of Malignant Female Reproductive System Neoplasm and Stage III Ovarian Cancer AJCC v8 that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 23 participants, below the 403-participant average among 18 other Malignant Female Reproductive System Neoplasm trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05786456, a NA study of Malignant Female Reproductive System Neoplasm and Stage III Ovarian Cancer AJCC v8, is active but no longer recruiting, sponsored by City of Hope Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

This clinical trial studies how well an electronic (e)-health intervention (day-by-day) woks in managing fears or worries about cancer growing, spreading, or getting worse (progression) in patients with stage III or IV gynecologic cancer. Fear and worries about cancer progression or recurrence (coming back) are common concerns. This may contribute to concerns related to illness, worries, and uncertainty about the future. Day by Day is adapted from a program called "Conquer Fear" which was shown to benefit patients with early-stage cancer. Day-by-day intervention may help refocus patient thoughts and help patients learn skills to manage anxiety and fears.

Interventions

  • OTHER Questionnaire Administration
  • OTHER Media Intervention
  • PROCEDURE Discussion
  • OTHER Informational Intervention
  • BEHAVIORAL Telephone-Based Intervention

Study Locations (1)

California

  • City of Hope Medical Center - Duarte

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2024-07-19
Est. Completion 2026-12-15
Phase NA

Sponsor

City of Hope Medical Center

582 total trials

What the Registry Record Tells You About NCT05786456

The ClinicalTrials.gov registry entry for NCT05786456 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 403-participant average among 18 other Malignant Female Reproductive System Neoplasm trials with a reported enrollment target (94% lower). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Malignant Female Reproductive System Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire Administration is the first listed.

NCT05786456 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05786456 about?

NCT05786456 is a clinical study titled "e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study". This clinical trial studies how well an electronic (e)-health intervention (day-by-day) woks in managing fears or worries about cancer growing, spreading, or getting worse (progression) in patients with stage III or IV gynecologic cancer. Fear and worries about cancer progression or recurrence (comi...

What is the current status of trial NCT05786456?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 23 participants. The study started on 2024-07-19. Estimated completion is 2026-12-15.

What conditions does trial NCT05786456 study?

This clinical trial studies the following conditions: Malignant Female Reproductive System Neoplasm, Stage III Ovarian Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage III Vulvar Cancer AJCC v8, Stage IV Cervical Cancer AJCC v8.

What interventions are being tested in trial NCT05786456?

The interventions under investigation include: Questionnaire Administration (OTHER), Media Intervention (OTHER), Discussion (PROCEDURE), Informational Intervention (OTHER), Telephone-Based Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05786456?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05786456 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Female Reproductive System Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.